Sort
64,565 grants matching “drug discovery”
Dynamics of the cellular interactome
$659,228James Edward Bruce · University Of Washington · R35 · FY2021 · GM
Dynamics of the cellular interactome
$659,228James Edward Bruce · University Of Washington · R35 · FY2024 · GM
Dynamics of the cellular interactome
$659,228James Edward Bruce · University Of Washington · R35 · FY2022 · GM
Structure-based drug discovery for Dopamine D2 Receptor Selective Ligands
$659,183Victoria Ahn · Confometrx, Inc. · R44 · FY2019 · MH
Discovery of synthetic and endogenous ligands for orphan GPCR GPR156
$659,164Cesare Orlandi · University Of Rochester · R01 · FY2024 · DC
Antibiotic Drug Discovery
$659,005Toni B. Kline · University Of Washington · U54 · FY2012 · AI
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers
$658,973Ben Shen · Scripps Florida · R01 · FY2018 · CA
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers
$658,973Ben Shen · Scripps Florida · R01 · FY2017 · CA
Novel Enediyne-Based Antibody-Drug Conjugates for Cancers
$658,973Ben Shen · Scripps Florida · R01 · FY2020 · CA
Identification of therapeutic targets for leukemia stem cells in AML-iPSC models
$658,908Eirini Papapetrou · Icahn School Of Medicine At Mount Sinai · R01 · FY2020 · CA
Research Infrastructure Core
$658,907Timothy Moore · Florida Agricultural And Mechanical Univ · U54 · FY2019 · MD
Echogenic Targeted Liposomes: Transfection/Drug Delivery
$658,867David D McPherson · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · HL
Molecular Mechanisms of Intestinal Epithelial Tight Junction Regulation
$658,854Jerrold R. Turner · University Of Chicago · R01 · FY2011 · DK
PROTEOME SIGNATURES AND TARGET VALIDATION IN LYMPHOMAS
$658,595Daniel G. Jay · Tufts University Boston · R33 · FY2008 · CA
Drug Abuse: Discovering Ligands for Pertinent GPCRs
$658,551Marc G. Caron · Duke University · P30 · FY2012 · DA
D1 and D2 Dopaminoceptive Ensembles in Limbic Brain Regions in Drug Addiction
$658,507Eric J Nestler · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · DA
Discovering compounds with robust pro-longevity activities
$658,502Gordon J. Lithgow · Buck Institute For Research On Aging · U01 · FY2014 · AG
Regulating dopamine transport through allosteric modulation - Functional and Behavioral Studies
$658,497Ole Valente Mortensen · Drexel University · R01 · FY2025 · DA
The Alzheimer's Disease Resiliome: Pathway Analysis and Drug Discovery.
$658,414Rudolph Emile Tanzi · Massachusetts General Hospital · R01 · FY2021 · AG
Novel Antifungals by Engineering the AbA NRPS gene
$658,406Ake P Elhammer · Aureogen Biosciences, Inc. · R44 · FY2007 · AI
Automated high throughput compound screening for broadly active anti-parasitic nematode drugs
$658,387Raffi V Aroian · Univ Of Massachusetts Med Sch Worcester · R01 · FY2021 · AI
Development of selective cannabinoid receptor 2 agonists for treatment of addiction
$658,362Mehrdad Shamloo · Stanford University · UH3 · FY2024 · NS
Chromatin regions, genes and pathways that confer susceptibility to chemical-induced DNA damage
$658,345Ivan Rusyn · Texas A&M Agrilife Research · R01 · FY2021 · ES
Small molecule modulators of ÎFosB
$658,323Gabrielle Rudenko · University Of Texas Med Br Galveston · R01 · FY2021 · DA
Transforming Life Sciences: Artificial Life
$658,230Steven A Benner · Foundation For Applied Molecular Evolutn · R01 · FY2019 · GM